A Third Form of Thrombotic Thrombocytopenic Purpura?

Overview

Journal Haematologica

Specialty Hematology

Date 2022 Apr 30

PMID 35488359

Authors

Bernhard Lammle

Affiliations

Soon will be listed here.

Citing Articles

Pathological Mechanisms and Novel Testing Methods in Thrombotic Thrombocytopenic Purpura.

Dolin H, Maitta R Biomedicines. 2024; 12(3).

PMID: 38540234 PMC: 10968366. DOI: 10.3390/biomedicines12030621.

References

Roose E, Schelpe A, Tellier E, Sinkovits G, Joly B, Dekimpe C . Open ADAMTS13, induced by antibodies, is a biomarker for subclinical immune-mediated thrombotic thrombocytopenic purpura. Blood. 2020; 136(3):353-361. DOI: 10.1182/blood.2019004221. View

Kremer Hovinga J, Coppo P, Lammle B, Moake J, Miyata T, Vanhoorelbeke K . Thrombotic thrombocytopenic purpura. Nat Rev Dis Primers. 2017; 3:17020. DOI: 10.1038/nrdp.2017.20. View

Ferrari S, Palavra K, Gruber B, Kremer Hovinga J, Knobl P, Caron C . Persistence of circulating ADAMTS13-specific immune complexes in patients with acquired thrombotic thrombocytopenic purpura. Haematologica. 2013; 99(4):779-87. PMC: 3971089. DOI: 10.3324/haematol.2013.094151. View

Mariotte E, Azoulay E, Galicier L, Rondeau E, Zouiti F, Boisseau P . Epidemiology and pathophysiology of adulthood-onset thrombotic microangiopathy with severe ADAMTS13 deficiency (thrombotic thrombocytopenic purpura): a cross-sectional analysis of the French national registry for thrombotic microangiopathy. Lancet Haematol. 2016; 3(5):e237-45. DOI: 10.1016/S2352-3026(16)30018-7. View

Scully M, Cataland S, Coppo P, De La Rubia J, Friedman K, Kremer Hovinga J . Consensus on the standardization of terminology in thrombotic thrombocytopenic purpura and related thrombotic microangiopathies. J Thromb Haemost. 2016; 15(2):312-322. DOI: 10.1111/jth.13571. View

Zheng X, Vesely S, Cataland S, Coppo P, Geldziler B, Iorio A . ISTH guidelines for the diagnosis of thrombotic thrombocytopenic purpura. J Thromb Haemost. 2020; 18(10):2486-2495. PMC: 8146131. DOI: 10.1111/jth.15006. View

Ferrari S, Scheiflinger F, Rieger M, Mudde G, Wolf M, Coppo P . Prognostic value of anti-ADAMTS 13 antibody features (Ig isotype, titer, and inhibitory effect) in a cohort of 35 adult French patients undergoing a first episode of thrombotic microangiopathy with undetectable ADAMTS 13 activity. Blood. 2006; 109(7):2815-22. DOI: 10.1182/blood-2006-02-006064. View

Roose E, Schelpe A, Joly B, Peetermans M, Verhamme P, Voorberg J . An open conformation of ADAMTS-13 is a hallmark of acute acquired thrombotic thrombocytopenic purpura. J Thromb Haemost. 2017; 16(2):378-388. DOI: 10.1111/jth.13922. View

Froehlich-Zahnd R, George J, Vesely S, Terrell D, Aboulfatova K, Dong J . Evidence for a role of anti-ADAMTS13 autoantibodies despite normal ADAMTS13 activity in recurrent thrombotic thrombocytopenic purpura. Haematologica. 2011; 97(2):297-303. PMC: 3269492. DOI: 10.3324/haematol.2011.051433. View

10.

Joly B, Roose E, Coppo P, Vanhoorelbeke K, Veyradier A . ADAMTS13 conformation is closed in non-immune acquired thrombotic thrombocytopenic purpura of unidentified pathophysiology. Haematologica. 2022; 108(2):638-644. PMC: 9892849. DOI: 10.3324/haematol.2022.280768. View